Trial intelligence / Profile preview

LIPSIA-N-ACC: Acetylcysteine in STEMI

NCT00463749Phase 3Completed

Sponsor
Leipzig University
Start
Dec 2006
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in myocardial infarction (MI), contrast-induced nephropathy (CIN), sponsored by Leipzig University. Started Dec 2006; status: completed.

02

Drugs

acetylcysteine
03

Conditions

myocardial infarction (MI)contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NCT00463749.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00463749.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call